Related Experiment Video
Updated: Nov 27, 2025

09:23
Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
Published on: March 10, 2023
4.5K
A Scalable Approach Reveals Functional Responses of iPSC Cardiomyocyte 3D Spheroids
Matthew P Burnham1,2, Rachel Harvey3, Rebecca Sargeant4
1Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Alderley Park, UK.
SLAS Discovery : Advancing Life Sciences R & D
|December 7, 2020
Summary
We developed a scalable, label-free 96-well plate system for 3D induced pluripotent stem cell-derived cardiomyocyte (iPSC-CM) spheroids. This method accurately measures contractility and electrical activity, improving cardiovascular drug discovery assays.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Stem Cell Biology
Background:
- Induced pluripotent stem cells (iPSCs) generate cardiomyocytes (CMs) for in vitro human myocardium models.
- 3D scaffolded cultures enhance iPSC-CM maturity but reduce throughput.
- Scalable, high-throughput methods for mature iPSC-CMs are needed for drug discovery.
Purpose of the Study:
- To develop a novel, scalable, label-free 96-well plate system for 3D iPSC-CM spheroid models.
- To enable simultaneous measurement of contractility and extracellular field potentials (EFPs) from iPSC-CM spheroids.
- To investigate factors influencing iPSC-CM spheroid function and pharmacological responses.
Main Methods:
- Developed a magnetic nanoparticle approach for precise spheroid positioning on electrodes.
- Utilized a 96-well plate format for label-free impedance and EFP measurements.
- Investigated effects of co-culture, buffer composition, and electrical pacing on spheroid function.
Main Results:
- Successfully detected contractility (impedance) and EFPs from beating iPSC-CM spheroids.
- Co-culture with fibroblasts increased beat amplitudes over 15-fold.
- Optimized conditions promoted physiological responses to inotropic agonists, enhancing force over rate.
Conclusions:
- Demonstrated a novel, scalable, label-free 96-well plate system for 3D iPSC-CM spheroid analysis.
- This method allows for label-free assessment of pharmacological responses in iPSC-CM spheroids.
- The system has potential applications in cardiovascular drug efficacy and safety screening, improving assay predictivity.

